Mesoblast Limited (MESO)
NASDAQ: MESO · IEX Real-Time Price · USD
7.40
-0.02 (-0.27%)
At close: Jul 26, 2024, 4:00 PM
7.30
-0.10 (-1.35%)
After-hours: Jul 26, 2024, 7:20 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $939.79 million as of July 26, 2024. Its market cap has increased by 47.00% in one year.
Market Cap
939.79M
Enterprise Value
984.23M
1-Year Change
47.00%
Ranking
Category
Stock Price
$7.40
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $939.79M, an increase of 58.43%. That is a compound annual growth rate of 5.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 753.00M | 320.44% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 979.03M |
| Humacyte | 970.53M |
| Immunome | 961.30M |
| 4D Molecular Therapeutics | 957.55M |
| 89bio | 950.39M |
| Pharvaris | 938.56M |
| Pacira BioSciences | 929.99M |
| Cronos Group | 924.47M |